Sign up
Quantellect · Congress · Trade Detail
NYSE: BSXBoston Scientific Corp
RepublicanHouse

Michael T. McCaul sold Boston Scientific Corp (NYSE: BSX)

Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 75 trades in Boston Scientific Corp (BSX) since 2019, 31 purchases and 44 sales, worth an estimated $3.5M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Michael T. McCaul sold $100,001 - $250,000 of Boston Scientific Corp (NYSE: BSX) on April 23, 2024. Since that trade, BSX is down -33.27% against the S&P 500 up +47.77%, an outperformance of -81.04%.

Across these filings, Michael T. McCaul has been a net seller of BSX (a buy-to-sell ratio of 0.70). The most recent disclosed BSX transaction shown was dated March 27, 2026. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BSX trades
75
Disclosed Vol
$3.5M
Buys
31
41%
Sells
44
59%
Buy / Sell
0.70
ratio
First → Last
2019–2026

Michael T. McCaul's BSX trades vs the price

BSX is down -33.27% since Michael T. McCaul sold on April 23, 2024, versus +47.77% for the S&P 500.

Performance since this trade

Price change since trade
-33.27%
S&P 500 change since trade
+47.77%
Outperformance vs S&P 500
-81.04%

All Michael T. McCaul BSX trades

TradedTypeSizeReturnEst. profit
March 27, 2026BUY$69.17-33.44%-$3K
April 24, 2024SELL$72.91-36.85%
April 24, 2024SELL$72.91-36.85%
April 23, 2024SELL$68.99-33.27%
April 23, 2024SELL$68.99-33.27%
April 12, 2024SELL$68.07-32.36%
April 12, 2024SELL$68.07-32.36%
December 18, 2023SELL$55.51-17.06%
December 18, 2023SELL$55.51-17.06%
October 31, 2023SELL$51.19-10.06%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Michael T. McCaul & BSX trading FAQ

Is it legal for Michael T. McCaul to trade Boston Scientific Corp (BSX) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Boston Scientific Corp (BSX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Michael T. McCaul sell BSX?

Michael T. McCaul disclosed a sale of $100,001 - $250,000 of Boston Scientific Corp (BSX) on April 23, 2024, according to public STOCK Act filings.

How has BSX performed since Michael T. McCaul's trade?

Since Michael T. McCaul sold BSX on April 23, 2024, the stock is down -33.27%, versus +47.77% for the S&P 500 over the same period, an outperformance of -81.04%.

How many times has Michael T. McCaul traded BSX?

Michael T. McCaul has disclosed 75 BSX trades since 2019 (31 purchases and 44 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BSX trades?

Quantellect tracks every disclosed congressional trade in Boston Scientific Corp (BSX) on the Boston Scientific Corp congressional trading page, which aggregates filings across all members of Congress.

Michael T. McCaul's BSX tradesAll congressional filings for Boston Scientific CorpMichael T. McCaul's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.